Company news: Reckitt Benckiser in talks on $16.9bn deal plus results from Shell, AstraZeneca and Vodafone

  • Home
  • /
  • Podcasts
  • /
  • Company news: Reckitt Benckiser in talks on $16.9bn deal plus results from Shell, AstraZeneca and Vodafone - 02 Feb 17
Ed Bowsher

Company news: Reckitt Benckiser in talks on $16.9bn deal plus results from Shell, AstraZeneca and Vodafone

Ed Bowsher
Original Broadcast:

Share Radio Afternoon

Company news: Reckitt Benckiser in talks on $16.9bn deal plus results from Shell, AstraZeneca and Vodafone
British consumer goods giant Reckitt Benckiser, which makes Nurofen amongst many other brands, is in advanced talks to buy baby formula company, Mead Johnson. Plus results from Shell, AstraZeneca and Vodafone - who's doing well and who's struggling? Share Radio's Ed Bowsher spoke with Richard Hunter, Head of Research at Wilson King Investment Management, for his take on the day's big company news.
Guest:

Richard Hunter


Published:

Topics: UK, AIM, M&A, FTSE, USA (in Shares)

Strand: Investment Perspectives


Listen
View all podcasts